The levels of the cytokine interleukin-6 (IL-6) and the heat-shock pro
tein hsp90 have both been reported to be elevated in patients with act
ive systemic lupus erythematosus (SLE). We show that hsp90 protein acc
umulates to increased levels in both HuH7 hepatoma cells and periphera
l blood mononuclear cells (PBMCs) treated with IL-6. In PBMCs this eff
ect occurs without induction of the other hsps, paralleling the specif
ic elevation of hsp90 in SLE. IL-6 is able to activate the hsp90 gene
promoter directly; this activation can also be achieved by overexpress
ing either of the transcription factors NF-IL-6 or NF-IL-6 beta whose
synthesis is induced by IL-6 treatment. Hence the induction of hsp90 p
rotein accumulation by IL-6 is likely to be dependent on the enhanced
activity of the hsp90 beta gene promoter produced by increased levels
of NF-IL-6 and/or NF-IL-6 beta. These effects are discussed in terms o
f the role of hsp90 in the normal immune system and the mechanism of i
ts activation in patients with SLE.